Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
C0q18Z45FsKD2MB9
